Showing results (201-210 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|December 22, 2015
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysisSeok Jin Kim, Joon Young Choi, Seung Hyup Hyun, et al.
The Lancet. Haematology|December 22, 2015
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation studyPatrice Chevallier, Thomas Eugene, Nelly Robillard, et al.
The Lancet. Haematology|December 22, 2015
One million haemopoietic stem-cell transplants: a retrospective observational studyAlois Gratwohl, Marcelo C Pasquini, Mahmoud Aljurf, et al.
The Lancet. Haematology|December 22, 2015
Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised studyChan Yoon Cheah, David Belada, Michelle A Fanale, et al.
The Lancet. Haematology|December 22, 2015
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trialAntonio Omuro, Olivier Chinot, Luc Taillandier, et al.
The Lancet. Haematology|December 22, 2015
Symptom burden of haematological malignancies as death approaches in a community palliative care service: a retrospective cohort study of a consecutive case seriesThomas W LeBlanc, Joanna M Smith, David C Currow
The Lancet. Haematology|December 22, 2015
Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics studyGiovanni Martinelli, Vivian G Oehler, Cristina Papayannidis, et al.
The Lancet. Haematology|April 12, 2016
Idiopathic multicentric Castleman's disease: a systematic literature reviewAmy Y Liu, Christopher S Nabel, Brian S Finkelman, et al.
The Lancet. Haematology|April 29, 2018
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trialMary Gleeson, Clare Peckitt, Ye Mong To, et al.
The Lancet. Haematology|July 24, 2018
Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association studyCarolyne M Ndila, Sophie Uyoga, Alexander W Macharia, et al.
Pageof 73